![Edward Benz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Benz
Directeur/Membre du Conseil chez
RENOVACOR, INC.
Fortune : - $ au 31/05/2026
Profil
Edward J.
Benz is Vice Chairman at The Mount Desert Island Biological Laboratory, Director at F-Star Biotechnologische Forschungs-.
Und Entwicklungsges MBH, Executive Director-Cure Sickle Cell Initiative at the National Institutes of Health, Director at The Rockefeller University, Director at Mount Desert Island Hospital, Inc., Director at Massachusetts Life Sciences Center since 2011, Independent Director at Candel Therapeutics, Inc. since 2017, Director at F-star Biotechnology Ltd. since 2020, Director at Knowledge to Practice, Inc. since 2015, Director at Renovacor Holdings, Inc. since 2017, Independent Director at Renovacor, Inc. since 2017, Director at CoRegen, Inc., Advisor at Riverside Partners LLC, and Trustee at Dana-Farber.
Former positions include President, Chief Executive Officer & Director at Dana-Farber Cancer Institute, Inc. from 2000 to 2016, Chief Executive Officer at Partners Cancercare, Chairman-Medicine Department & Professor at The Johns Hopkins University School of Medicine from 1995 to 2000, Director at Dana-Farber from 2000 to 2016, Director at F-Star Therapeutics, Inc. (United States), Director at Xenetic Biosciences, Inc. from 2016 to 2017, Independent Director at F-star Therapeutics, Inc. from 2019 to 2023, Independent Director at Deciphera Pharmaceuticals, Inc. from 2019 to 2024, President of the American Society of Hematology, President of the American Society for Clinical Investigation, Dean at Harvard Medical School in 2000, President of the Association of American Cancer Institutes, Associate Editor of the New England Journal of Medicine, President of Friends of The National Institute of Nursing Research, and President of the American Clinical & Climatological Association.
Education includes graduate studies at Yale University, undergraduate degree from Princeton University in 1968, and a doctorate from Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Edward Benz
| Sociétés | Poste | Début |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2017 |
| RENOVACOR, INC. | Directeur/Membre du Conseil | 01/07/2017 |
CoRegen, Inc.
 CoRegen, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops medicines for cancer and high intensity chronic illnesses | Directeur/Membre du Conseil | - |
Riverside Partners LLC
 Riverside Partners LLC Investment ManagersFinance Riverside Partners invests in middle-market companies located in the United States primarily in North America with an EBITDA of USD 3 - 15 million. The firm focuses on technology and healthcare sectors. It participates in buyouts, recapitalizations, growth equity, divestitures, take private transactions and strategic add-on acquisitions. It makes control investments. | Consultant / Advisor | - |
Dana-Farber/Boston Children'S Cancer & Blood Disorders Center
 Dana-Farber/Boston Children'S Cancer & Blood Disorders Center 'The company is based in Boston. Part of Dana-Farber Cancer Institute, Inc., Dana-Farber/Boston Children'S Cancer & Blood Disorders Center is an American company. | Directeur/Membre du Conseil | - |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Directeur/Membre du Conseil | - |
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 09/01/2020 |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Directeur/Membre du Conseil | 01/07/2017 |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
| ░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Edward Benz
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Edward Benz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
31
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 31 |
|---|---|
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Health Technology |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Riverside Partners LLC
Riverside Partners LLC Investment ManagersFinance Riverside Partners invests in middle-market companies located in the United States primarily in North America with an EBITDA of USD 3 - 15 million. The firm focuses on technology and healthcare sectors. It participates in buyouts, recapitalizations, growth equity, divestitures, take private transactions and strategic add-on acquisitions. It makes control investments. | Finance |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
American Society for Clinical Investigation
 American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Health Technology |
Dana-Farber/Harvard Cancer Center
 Dana-Farber/Harvard Cancer Center Hospital/Nursing ManagementHealth Services Operates as cancer center | Health Services |
Mount Desert Island Hospital, Inc.
 Mount Desert Island Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
The Mount Desert Island Biological Laboratory
 The Mount Desert Island Biological Laboratory BiotechnologyHealth Technology Engages in research and development of biotechnology | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Life Sciences Center
 Massachusetts Life Sciences Center Investment ManagersFinance Functions as a Pension/Retirement Fund | Finance |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Association of American Cancer Institutes
 Association of American Cancer Institutes Miscellaneous Commercial ServicesCommercial Services Operates as a membership association and cancer research center | Commercial Services |
New England Journal of Medicine
 New England Journal of Medicine Packaged SoftwareTechnology Services Develops medical software | Technology Services |
Partners Cancercare | |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-star Biotechnology Ltd.
F-star Biotechnology Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Xenetic Biosciences, Inc.
 Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
Knowledge to Practice, Inc.
 Knowledge to Practice, Inc. Miscellaneous Commercial ServicesCommercial Services Provides personalized and adaptive learning solutions | Commercial Services |
Friends of The National Institute of Nursing Research | |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
American Clinical & Climatological Association | |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
Dana-Farber/Boston Children'S Cancer & Blood Disorders Center
Dana-Farber/Boston Children'S Cancer & Blood Disorders Center 'The company is based in Boston. Part of Dana-Farber Cancer Institute, Inc., Dana-Farber/Boston Children'S Cancer & Blood Disorders Center is an American company. | |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases | Health Technology |
CoRegen, Inc.
CoRegen, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops medicines for cancer and high intensity chronic illnesses | Commercial Services |
